Chiam Yu Ng

Chiam Yu Ng

Auto-generated profile, based on publicly available information

Chiam Yu Ng

Department of Chemical Engineering, The Pennsylvania State University, University Park, PA, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2019 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
LHLaurent Heirendt
Laurent Heirendt
SASylvain Arreckx
Sylvain Arreckx
TPThomas Pfau
Thomas Pfau
SMSebastián N. Mendoza
Sebastián N. Mendoza
ARAnne Richelle
Anne Richelle
RFRonan MT Fleming
Ronan MT Fleming

1 May 2015 in Metabolic Engineering
Verified
Journal Article
Closed access
CNChiam Yu Ng
Chiam Yu Ng
IFIman Farasat
Iman Farasat
CMCostas D. Maranas
Costas D. Maranas
HSHoward M. Salis
Howard M. Salis

28 May 2012 in Microbial Cell Factories
Verified
Journal Article
Open access
PDF file
CNChiam Yu Ng
Chiam Yu Ng
MJMoo-Young Jung
Moo-Young Jung
JLJinwon Lee
Jinwon Lee
MOMin-Kyu Oh
Min-Kyu Oh
Background: 2,3-Butanediol is a chemical compound of increasing interest due to its wide applications. It can be synthesized via mixed acid fermentation of pathogenic bacteria such as Enterobacter aerogenes and Klebsiella oxytoca. The non-pathogenic Saccharomyces cerevisiae possesses three different 2,3-butanediol biosynthetic pathways, but produces minute amount of 2,3-butanediol. Hence, we attempted to engineer S. cerevisiae strain to enhance 2,3-butanediol production. Results: We first identified gene deletion strategy by performing in silico genome-scale metabolic analysis. Based on the best in silico strategy, in which disruption of alcohol dehydrogenase (ADH) pathway is required, we then constructed gene deletion mutant strains and performed batch cultivation of the strains. Deletion of three ADH genes, ADH1, ADH3 and ADH5, increased 2,3-butanediol production by 55-fold under microaerobic condition. However, overproduction of glycerol was observed in this triple deletion strain. Additional rational design to reduce glycerol production by GPD2 deletion altered the carbon fluxes back to ethanol and significantly reduced 2,3-butanediol production. Deletion of ALD6 reduced acetate production in strains lacking major ADH isozymes, but it did not favor 2,3-butanediol production. Finally, we introduced 2,3-butanediol biosynthetic pathway from Bacillus subtilis and E. aerogenes to the engineered strain and successfully increased titer and yield. Highest 2,3-butanediol titer (2.29 g·l-1) and yield (0.113 g·g-1) were achieved by Δadh1 Δadh3 Δadh5 strain under anaerobic condition. Conclusions: With the aid of in silico metabolic engineering, we have successfully designed and constructed S. cerevisiae strains with improved 2,3-butanediol production.

1 December 2017 in Synthetic and Systems Biotechnology
Verified
Journal Article
Open access
LWLin Wang
Lin Wang
SDSatyakam Dash
Satyakam Dash
CNChiam Yu Ng
Chiam Yu Ng
CMCostas D. Maranas
Costas D. Maranas
Metabolic pathways reflect an organism's chemical repertoire and hence their elucidation and design have been a primary goal in metabolic engineering. Various computational methods have been developed to design novel metabolic pathways while taking into account several prerequisites such as pathway stoichiometry, thermodynamics, host compatibility, and enzyme availability. The choice of the method is often determined by the nature of the metabolites of interest and preferred host organism, along with computational complexity and availability of software tools. In this paper, we review different computational approaches used to design metabolic pathways based on the reaction network representation of the database (i.e., graph or stoichiometric matrix) and the search algorithm (i.e., graph search, flux balance analysis, or retrosynthetic search). We also put forth a systematic workflow that can be implemented in projects requiring pathway design and highlight current limitations and obstacles in computational pathway design.

12 January 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
AKAkhil Kumar
Akhil Kumar
LWLin Wang
Lin Wang
CNChiam Yu Ng
Chiam Yu Ng
CMCostas D. Maranas
Costas D. Maranas
Existing retrosynthesis tools generally traverse production routes from a source to a sink metabolite using known enzymes or de novo steps. Generally, important considerations such as blending known transformations with putative steps, complexity of pathway topology, mass conservation, cofactor balance, thermodynamic feasibility, microbial chassis selection, and cost are largely dealt with in a posteriori fashion. The computational procedure we present here designs bioconversion routes while simultaneously considering any combination of the aforementioned design criteria. First, we track and codify as rules all reaction centers using a prime factorization-based encoding technique (rePrime). Reaction rules and known biotransformations are then simultaneously used by the pathway design algorithm (novoStoic) to trace both metabolites and molecular moieties through balanced bio-conversion strategies. We demonstrate the use of novoStoic in bypassing steps in existing pathways through putative transformations, assembling complex pathways blending both known and putative steps toward pharmaceuticals, and postulating ways to biodegrade xenobiotics.

3 February 2012 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
MJMoo-Young Jung
Moo-Young Jung
CNChiam Yu Ng
Chiam Yu Ng
HSHyohak Song
Hyohak Song
JLJinwon Lee
Jinwon Lee
MOMin-Kyu Oh
Min-Kyu Oh